
The episode discusses the disappointing results of the Enhanced Games, Eli Lilly's breakthrough in weight loss, and the hosts' mission to interview Warren Buffett while updating the Community Portfolio.
The Enhanced Games promised superhuman performances, but the results told a different story. Meanwhile, Eli Lilly delivered another breakthrough in the race to dominate the global weight loss market. Plus, Bryce & Ren reveal their mission to land Warren Buffett on the podcast, and a community member pitches an Aussie healthcare giant for the Community Portfolio. In this episode: 00:00 – The Enhanced Games fail to deliver superhuman results 05:18 – Eli Lilly’s new weight loss drug shocks the market 10:49 – Where's Warren: Our Mission to Interview Warren Buffett 15:03 – Calling Omaha to track down Buffett 16:48 – Geoff Wilson gets us one step closer 20:09 – The plan to contact Buffett’s longtime assistant 22:28 – Community Portfolio update: Are we beating the market? 24:29 – Josh pitches ResMed for the Community Portfolio Enhanced Games (NASDAQ: ENHA), Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), Berkshire Hathaway (NYSE: BRK.B), Taiwan Semiconductor Manufacturing Company (NYSE: TSM), ResMed (ASX: RMD), Catapult Group (ASX: CAT), Betashares Diversified All Growth ETF (ASX: DHHF), CSL (ASX: CSL), Cochlear (ASX: COH), Philips (AMS: PHIA) ——— Want to get involved in the…
Hosts: Bryce, Ren
Organizations: Enhanced Games, Eli Lilly, Warren Buffett, ResMed, Berkshire Hathaway, Taiwan Semiconductor Manufacturing Company, Novo Nordisk, Catapult Group, Betashares Diversified All Growth ETF, CSL
Explore listener stats, chart rankings, contacts and more on the Equity Mates Investing Podcast podcast page.